S&P Futures
4,256.50 -30.00 (-0.70%) Dow Futures
33,804.00 -177.00 (-0.52%) Nasdaq Futures
13,407.25 -116.00 (-0.86%) Russell 2000 Futures
1,984.40 -17.30 (-0.86%) Crude Oil
89.59 -0.91 (-1.01%) Gold
1,767.20 -4.00 (-0.23%)
Gemini Therapeutics, Inc. (GMTX)
Chart Events
Performance Outlook
| Previous Close | 1.8000 |
| Open | 1.8000 |
| Bid | 0.0000 x 1800 |
| Ask | 0.0000 x 1000 |
| Day's Range | 1.6300 - 1.8000 |
| 52 Week Range | 1.1600 - 5.4800 |
| Volume | |
| Avg. Volume | 173,429 |
| Market Cap | 70.921M |
| Beta (5Y Monthly) | -0.11 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.5770 |
| Earnings Date | Nov 14, 2022 - Nov 18, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.75 |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for GMTX
Related Research
- Gemini Therapeutics, Inc.Daily – Vickers Top Buyers & Sellers for 04/14/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.RatingFair ValueEconomic Moat4 months agoArgus Research
- American City Business Journals
Blood disorder startup goes public by merging with embattled biotech
At three years old, an Atlas Venture spinout focused on blood disorders is going public by merging with another local biotech company.
- Business Wire
Gemini Therapeutics and Disc Medicine Announce Merger Agreement
WAYLAND, Mass. & WATERTOWN, Mass., August 10, 2022--Gemini Therapeutics, Inc. (Nasdaq: GMTX) ("Gemini") and Disc Medicine, Inc. ("Disc"), a privately-held, clinical-stage biopharmaceutical company focused on the discovery and development of novel treatments for patients suffering from serious hematologic diseases, announced today that they have entered into a definitive merger agreement to combine the companies in an all-stock transaction. The combined company will focus on advancing Disc’s pipe
- Simply Wall St.
Insider Buying: Braden Leonard Just Spent US$75k On Gemini Therapeutics, Inc. (NASDAQ:GMTX) Shares
Even if it's not a huge purchase, we think it was good to see that Braden Leonard, a Gemini Therapeutics, Inc...
